Professor, Neurology, University of Arizona College of Medicine
Neurology
Dr. David M. Treiman, MD
|
|
Give Review
David M. Treiman, MD practices Neurology. He studied medicine at Stanford University School of Medicine. Stanford University School of Medicine is a top medical college. Stanford University School of Medicine is ranked 2/25 in Research/PrimaryCare. David Treiman is also a published physician. He has 99 paper published. The most recent paper is: Phenytoin penetration into brain after administration of phenytoin or fosphenytoin. David M. Treiman, MD accepts all Medicare patients.
Publications
- Sparse and distributed coding of episodic memory in neurons of the human hippocampus.
- Commentary: On better research and writing in clinical epilepsy.
- Control of synchronization of brain dynamics leads to control of epileptic seizures in rodents.
- Nonconvulsive status epilepticus: Epilepsy Research Foundation workshop reports.
- GABAergic mechanisms in epilepsy.
- Status epilepticus and tiagabine therapy: review of safety data and epidemiologic comparisons.
- Therapy of status epilepticus in adults and children.
- Neocortical status epilepticus.
- Altered residual ATP content in rat brain cortex subcellular fractions following status epilepticus induced by lithium and pilocarpine.
- Violence and the epilepsy defense.
- Phenytoin penetration into brain after administration of phenytoin or fosphenytoin.
- A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group.
- Effects of cholinergic deafferentation and NGF on brain electrical coherence.
- Clinical trials for status epilepticus.
- Reduced cortical ecto-ATPase activity in rat brains during prolonged status epilepticus induced by sequential administration of lithium and pilocarpine.
- Changes in cortical EEG and cholinergic function in response to NGF in rats with nucleus basalis lesions.
- Rational polytherapy in the treatment of status epilepticus.
- High-performance liquid chromatographic determination of midazolam in rat brain.
- Lamotrigine vs. phenytoin for treatment of status epilepticus: comparison in an experimental model.
- Rising dose study of safety and tolerance of flunarizine.
- Neuron specific enolase and status epilepticus-induced neuronal injury.
- Generalized convulsive status epilepticus in the adult.
- Increasing plasma concentration tolerability study of flunarizine in comedicated epileptic patients.
- Current treatment strategies in selected situations in epilepsy.
- Ethical considerations.
- Study population selection.
- Interictal spiking increases 2-deoxy[14C]glucose uptake and c-fos-like reactivity.
- Effect of an adenosine antagonist and an adenosine agonist on status entry and severity in a model of limbic status epilepticus.
- Markedly increased mesiotemporal lobe metabolism in a case with PLEDs: further evidence that PLEDs are a manifestation of partial status epilepticus.
- Dezinamide for partial seizures: results of an n-of-1 design trial.
- Flunarizine for treatment of partial seizures: results of a concentration-controlled trial.
- Efficacy and tolerance of long-term, high-dose gabapentin: additional observations.
- A new, non-pharmacologic model of convulsive status epilepticus induced by electrical stimulation: behavioral/electroencephalographic observations and response to phen...
- Functional mapping of the late stages of status epilepticus in the lithium-pilocarpine model in rat: a 14C-2-deoxyglucose study.
- Functional mapping of the early stages of status epilepticus: a 14C-2-deoxyglucose study in the lithium-pilocarpine model in rat.
- Cardiac hypertrophy secondary to status epilepticus in the rat.
- Treatment of experimental status epilepticus with the GABA uptake inhibitor, tiagabine.
- Electroclinical features of status epilepticus.
- Palinopsia reconsidered.
- Complex partial seizures on closed-circuit television and EEG: a study of 691 attacks in 79 patients.
- Current concepts in neurology: management of status epilepticus.
- Complex partial status epilepticus.
- Status epilepticus: summary.
- General principles of treatment: responsive and intractable status epilepticus in adults.
- The treatable epilepsies.
- The treatable epilepsies. (Second of Two Parts).
- Interaction of genotype and environment as determinants of corticosteroid response to stress.
- Phenylalanine hydroxylase in dilute lethal mice.
- Developmental biology of hepatic phenylalanine hydroxylase activity in foetal and neonatal rats synchronized as to conception.
- Plasma corticosteroid response to stress in four species of wild mice.
- The structural gene for O-acetylserine sulfhydrylase A in Salmonella typhimurium. Identity with the trzA locus.
- Efficacy of nafimidone in the treatment of intractable partial seizures: report of a two-center pilot study.
- Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures.
- Vigabatrin for refractory complex partial seizures: multicenter single-blind study with long-term follow-up.
- Epilepsy and violence: medical and legal issues.
- Pharmacokinetics of nafimidone in patients with chronic intractable epilepsy.
- High-performance liquid chromatographic determination of nafimidone and its major metabolite nafimidone alcohol in human plasma and urine.
- Response of status epilepticus induced by lithium and pilocarpine to treatment with diazepam.
- Simultaneous high-performance liquid chromatographic determination of carbamazepine and its principal metabolites in human plasma and urine.
- Determination of lorazepam in plasma of patients during status epilepticus by high-performance liquid chromatography.
- Experimental secondarily generalized convulsive status epilepticus induced by D,L-homocysteine thiolactone.
- Pharmacokinetic profile of flunarizine after single and multiple dosing in epileptic patients receiving comedication.
- Clinical benefits of vigabatrin.
- Efficacy and safety of antiepileptic drugs: a review of controlled trials.
- Inhibition of carbamazepine and phenytoin metabolism by nafimidone, a new antiepileptic drug.
- Effect of gamma-vinyl GABA on interictal spikes and sharp waves in patients with intractable complex partial seizures.
- gamma Vinyl GABA: current role in the management of drug-resistant epilepsy.
- Pharmacokinetics and clinical use of benzodiazepines in the management of status epilepticus.
- A multicentre study of vigabatrin for drug-resistant epilepsy.
- Phenobarbital treatment of status epilepticus in a rodent model.
- Lorazepam treatment of experimental status epilepticus in the rat: relevance to clinical practice.
- Efficacy of ACC-9653 (a phenytoin prodrug) in experimental status epilepticus in the rat.
- A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus.
- Generic substitutions for antiepileptic drugs.
- Analysis of lorazepam in rat brain using liquid/liquid and solid-phase extraction in combination with high performance liquid chromatography.
- The role of benzodiazepines in the management of status epilepticus.
- Multicenter long-term safety and efficacy study of vigabatrin for refractory complex partial seizures: an update.
- Psychobiology of ictal aggression.
- High-performance liquid chromatographic determination of selected amino acids in rat brain by precolumn derivatization with phenylisothiocyanate.
- Brain amino acid concentration changes during status epilepticus induced by lithium and pilocarpine.
- Motor and electroencephalographic response of refractory experimental status epilepticus in rats to treatment with MK-801, diazepam, or MK-801 plus diazepam.
- Hippocampal pyramidal cell loss in human status epilepticus.
- Design of an individualized fixed-dose clinical trial to test the antiepileptic efficacy of a plasma flunarizine concentration.
- Pharmacologic approaches to the treatment of focal seizures. Past, present, and future.
- Valproic acid treatment of experimental status epilepticus.
- Brain amino acid concentrations during specific electroencephalographic stages of status epilepticus in the rat.
- DIFFERENTIAL PLASMA CORTICOSTERONE RESPONSE TO STRESS IN FOUR INBRED STRAINS OF MICE.
- Brain dynamical disentrainment by anti-epileptic drugs in rat and human status epilepticus.
- An inexpensive method for control of methyl-methacrylate fumes in the laboratory.
- Problems and controversies in status epilepticus: a review and recommendations.
- Neurons in the human hippocampus and amygdala respond to both low and high level image properties.
- Nonlinear dynamics of seizure prediction in a rodent model of epilepsy.
- Management of refractory complex partial seizures: current state of the art.
- Levetiracetam: a comprehensive review.
- Status epilepticus associated with subtentorial posterior fossa lesions.
- Epilepsy and aggression: proceed with caution.
- Treatment of seizure emergencies: convulsive and non-convulsive status epilepticus.
- Will brain damage after status epilepticus be history in 2010?
Schools
Stanford University School Of Medicine
Duke University School Of Medicine Durham Nc
Duke University Medical Center Neurology
Procedures Preformed
- EEG (Electroencephalogram)
- EMG (Electromyography)
- Epilepsy Surgery
- Management of VNS Devices for the Treatment of Epilepsy
Doctors Specialties
- Clinical Neurophysiology
- Epilepsy
- Neurology
Accepted Insurances
Education
-
Duke University Hospital -
Stanford University School of Medicine
Hospital
-
St. Joseph's Hospital and Medical Center
Drug Facts
| NPI NUMBER | 1285742791 | |
| NPPES Provider LastName | TREIMAN | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 850134224 | |
| NPPES Provider State | AZ | |
| Specialty Description | Neurology | |
| Total Claim Count | 1127.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1285742791 |
| Last Name Of The Provider | TREIMAN |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
Dr. Melanie Alarcio, MD |
|
Dr. Kris A. Smith, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joshua A. Tobin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Johan E. Samanta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David A. Weidman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Darin T. Okuda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scot G. Fechtel, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Matthew M. Troester, DO |
|
|
Dr. Matthew T. Hoerth, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Laura L. Lehnhoff, MD |
|
Dr. Steve S. Chung, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Vladimir Shvarts, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jaswant S. Sachdev, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ales Hlubocky, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Korwyn Williams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Timothy J. Yu, MD |
|
|
Dr. Aashish R. Patel, DO
This Doctor is OpenDoctor Recommended.
|
|
Dr. Leslie A. Friedman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Joni M. Clark, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Victor Salazar-Calderon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Todd D. Levine, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. David S. Gloss, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jay M. Uomoto, PHD |
|
Dr. Ming-Jai Liu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thandar Aung, MD |
|
Dr. Gregory Y. Chang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Norman C. Wang, MD
This Doctor is OpenDoctor Recommended.
|